SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.
SD BioSensor Dividend Announcement
• SD BioSensor announced a semi annually dividend of ₩290.00 per ordinary share which will be made payable on 2023-04-14. Ex dividend date: 2022-12-28
• SD BioSensor's trailing twelve-month (TTM) dividend yield is -%
• SD BioSensor's payout ratio for the trailing twelve months (TTM) is -0.04%
SD BioSensor Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2022-12-28 | ₩290.00 | semi annually | 2023-04-14 |
2022-06-29 | ₩700.00 | semi annually | 2022-08-31 |
2021-12-29 | ₩1266.00 | semi annually | 2022-04-15 |
SD BioSensor Dividend per year
SD BioSensor Dividend Yield
SD BioSensor current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SD BioSensor stock? Use our calculator to estimate your expected dividend yield:
SD BioSensor Financial Ratios
SD BioSensor Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy SD BioSensor stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.